Literature DB >> 26113443

Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women.

Lorena Mejía1, Diana Muñoz1, Gabriel Trueba1, Leopoldo Tinoco2, Sonia Zapata1.   

Abstract

Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide and it is responsible for most cases of uterine cancer. In Ecuador there is limited information about HPV types (and variants) in cancerous lesions; however, identifying the type-specific HPV prevalence in cervical lesions of women living in Ecuador is important to better predict the impact of HPV prophylactic vaccination in this country. We studied the prevalence of HPV types in cervical cancerous or precancerous lesions from 164 Ecuadorian women and found that 86.0% were HPV positive. The most common types were HPV16 (41.8%) and HPV58 (30.5%). Interestingly, HPV18 was detected only in 2.8% of the HPV-positive samples. Fifteen DNA sequences (genes E6 and L1) from 16 samples positive for HPV16 belonged to the European lineage, considered one of the least carcinogenic lineages, and 1 (6.25%) to the Asian-American lineage. Similar analysis in 12 HPV58 positive samples showed that 10 (83.3%) sequences grouped in sublineage A2, which belongs to the oldest HPV58 lineage, 1 belonged to A3 and 1 to lineage C. This study suggests that the currently used HPV vaccines (bivalent and tetravalent) may have lower effectiveness in Ecuador than in other geographic locations where HPV18 is more prevalent.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ecuador; HPV16 variants; HPV58 variants; cervical cancer

Mesh:

Year:  2015        PMID: 26113443     DOI: 10.1002/jmv.24310

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Follow-up study of HPV58 variants in women with incident HPV58 infection from a Colombian cohort.

Authors:  Mónica Molano; Oscar Buitrago; Pablo Moreno-Acosta; Suzanne M Garland; Nicolás Morales; Antonio Huertas; Teresa Martinez; Oscar Gamboa; Sepehr N Tabrizi; Alyssa Cornall; Nubia Muñoz
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

2.  Characterisation of complete high- and low-risk human papillomavirus genomes isolated from cervical specimens in southern Brazil.

Authors:  Gisele R de Oliveira; Juliana D Siqueira; Fabiana Finger-Jardim; Valdimara C Vieira; Ronald L Silva; Carla V Gonçalves; Esmeralda A Soares; Ana Maria Barral de Martinez; Marcelo A Soares
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-10       Impact factor: 2.743

3.  Prevalence of High-Risk Genotypes of Human Papillomavirus: Women Diagnosed with Premalignant and Malignant Pap Smear Tests in Southern Ecuador.

Authors:  Paola Dalgo Aguilar; Cisne Loján González; Ana Córdova Rodríguez; Katherine Acurio Páez; Ana Paulina Arévalo; Jana Bobokova
Journal:  Infect Dis Obstet Gynecol       Date:  2017-06-22

4.  Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.

Authors:  Intisar Salim Pity; Hanaa Mohammed Abdo; Amer Abdalla Goreal
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

5.  Frequency and distribution of HPV genotypes in 800 genital samples of Ecuadorian men and women from the city of Guayaquil.

Authors:  Gustavo David García Muentes; Marcia Adelaida Mendoza García; Ramiro Israel Burgos Galárraga; Kleber Ollague; Cynthia Vargas Wachter; Juan Carlos Ruiz Cabezas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-08-19       Impact factor: 1.846

6.  Expression Analysis of MIST1 and EMT Markers in Primary Tumor Samples Points to MIST1 as a Biomarker of Cervical Cancer.

Authors:  Wei Wang; Xin Xie; Zhangjian Zhou; Hao Zhang
Journal:  Int J Gen Med       Date:  2021-04-14

7.  A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.

Authors:  Pinghong Ming; Ting Cai; Jin Li; Yong Ning; Shengao Xie; Tao Tao; Faqing Tang
Journal:  Oncotarget       Date:  2016-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.